Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
People
Carothers Award To Paul Anderson
by Linda Wang
August 19, 2013
| A version of this story appeared in
Volume 91, Issue 33
Paul S. Anderson, a past-president of the American Chemical Society, is the winner of the 2013 Wallace H. Carothers Award from the ACS Delaware Section. The award recognizes outstanding contributions to and advances in industrial applications of chemistry. It includes a $2,000 cash prize.
Anderson’s career in the pharmaceutical industry spanned nearly 40 years, first at Merck & Co. and later at DuPont-Merck Pharmaceutical and Bristol-Myers Squibb. He was involved in the synthesis of numerous compounds that went on to become leading pharmaceutical products, including the HIV protease inhibitor Crixivan and the HIV reverse transcriptase inhibitor Sustiva.
Anderson served as ACS president in 1997. He was awarded ACS’s highest honor, the Priestley Medal, in 2006.
Linda Wang compiles this section. Announcements of awards may be sent to l_wang@acs.org.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter